Beyond bacterial load: Strengthening the evidence for poloxamer-based ophthalmic solutions in cataract surgery

Abstract

Get full access to this article

View all access options for this article.

References

Martucci

Zanotto

Corsi

, et al. The performance of an ophthalmic solution containing Poloxamer 407 and Polyquaternium 133 in reducing conjunctival bacterial load in patients receiving cataract surgery: a randomized trial. Eur J Ophthalmol 2025. doi:10.1177/11206721251375236

Chomchalao

Saelim

Lamlertthon

, et al. A potential thermosensitive poloxamer 407-based in situ hydrogel containing moxifloxacin-loaded silk fibroin nanoparticles for prolonged ocular delivery. J Drug Deliv Sci Technol 2024; 99: 105988. doi:10.1016/j.jddst.2024.105988

Almeida

Amaral

Lobão

, et al. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert Opin Drug Deliv 2013; 10: 1223–1237. doi:10.1517/17425247.2013.796360